FHIT and non-small cell lung carcinoma: In addition, aberrant FHIT hypermethylation is also not significantly higher in advanced NSCLC (III & IV) than that in early staged NSCLC (I & II), OR = 1.04, 95% CI = 0.77–1.41, p = 0.79, Fig. 6B.